Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

Share Price is delayed by 15 minutes
Get Live Data
98.90    -1.20 (-1.20%)
Bid:
99.22
Ask:
99.28
Spread: 0.06 (0.06%)
Market Cap: £57.64b
LLOY Live PriceLast checked at - London Stock Exchange

Intraday Lloyds Share Chart

Publication of Final Terms

10 Feb 2026 14:14

RNS Number : 4704S
Lloyds Banking Group PLC
10 February 2026
 

10 February 2026

Publication of Final Terms

The following Final Terms are available for viewing:

Final Terms dated 10 February 2026, for the EUR 750,000,000 Floating Rate Callable Notes due 2030 (the "2030 Notes Final Terms") and Final Terms dated 10 February 2026, for the EUR 750,000,000 3.750 per cent. Fixed Rate Reset Callable Notes due 2037 (the "2037 Notes Final Terms" and, together with the 2030 Notes Final Terms, the "Final Terms") (together, the "Notes") issued by Lloyds Banking Group plc pursuant to the base prospectus dated 21 March 2025 and the supplemental prospectuses dated 1 May 2025, 24 July 2025, 5 August 2025, 23 October 2025 and 30 January 2026, which together constitute a base prospectus (the "Prospectus") in connection with the £25,000,000,000 Euro Medium Term Note Programme established by Lloyds Banking Group plc.

The respective Final Terms for the Notes contain the final terms of the respective series of Notes. Each Final Terms must be read in conjunction with the Prospectus, which constitutes a base prospectus for the purposes of Regulation (EU) 2017/1129 as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (as amended).

To view the full documents, please paste the following URLs into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/4704S_2-2026-2-10.pdf

http://www.rns-pdf.londonstockexchange.com/rns/4704S_1-2026-2-10.pdf

A copy of each Final Terms and the Prospectus have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information, please contact:

Investor Relations:

Douglas RadcliffeGroup Investor Relations DirectorTel: +44 20 7356 1571Email: douglas.radcliffe@lloydsbanking.com 

Group Corporate Affairs:

Matt SmithHead of Media RelationsTel: +44 (0) 7788 352 487Email: matt.smith@lloydsbanking.com

Lloyds Banking Group plcRegistered OfficeThe MoundEdinburgh EH1 1YZ

Disclaimer - Intended Addressees

Please note that the information contained in each Final Terms and the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the relevant Final Terms or the Prospectus is not addressed. Prior to relying on the information contained in either Final Terms or the Prospectus, you must ascertain from the relevant Final Terms and/or the Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

EU MiFID II/UK MiFIR (Product Governance) - professionals and ECPs-only / No EU or UK PRIIPs KID - Manufacturer target market (EU MiFID II product governance and UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No EU PRIIPs or UK PRIIPs key information document (KID) has been prepared as the Notes are not available to retail in the EEA or in the United Kingdom.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTBSGDDBBBDGLG
Date   Source Headline
28th Mar 20255:26 pmRNSTransaction in Own Shares
28th Mar 20252:16 pmRNSPublication of a Prospectus
27th Mar 20255:35 pmRNSTransaction in Own Shares
26th Mar 20255:36 pmRNSTransaction in Own Shares
25th Mar 20255:28 pmRNSTransaction in Own Shares
24th Mar 20255:35 pmRNSTransaction in Own Shares
24th Mar 20253:00 pmRNSDirector/PDMR Shareholding
21st Mar 20255:58 pmRNSTransaction in Own Shares
21st Mar 20254:27 pmRNSPublication of a Prospectus
20th Mar 20255:35 pmRNSTransaction in Own Shares
19th Mar 20255:53 pmRNSTransaction in Own Shares
19th Mar 202511:38 amRNSNotice of AGM
18th Mar 20255:33 pmRNSTransaction in Own Shares
17th Mar 20255:40 pmRNSTransaction in Own Shares
14th Mar 20255:53 pmRNSTransaction in Own Shares
13th Mar 20255:45 pmRNSTransaction in Own Shares
13th Mar 20254:00 pmRNSDirector/PDMR Shareholding
12th Mar 20255:44 pmRNSTransaction in Own Shares
11th Mar 20256:11 pmRNSTransaction in Own Shares
11th Mar 20254:31 pmRNSDirector/PDMR Shareholding
10th Mar 20255:48 pmRNSTransaction in Own Shares
10th Mar 20252:00 pmRNSDirector/PDMR Shareholding
7th Mar 20255:40 pmRNSTransaction in Own Shares
7th Mar 20252:00 pmRNSDirector/PDMR Shareholding
6th Mar 20255:45 pmRNSTransaction in Own Shares
6th Mar 20253:30 pmRNSDirector/PDMR Shareholding
5th Mar 20255:33 pmRNSTransaction in Own Shares
4th Mar 20255:54 pmRNSTransaction in Own Shares
4th Mar 20254:07 pmRNSPublication of Final Terms
3rd Mar 20255:39 pmRNSTransaction in Own Shares
28th Feb 20256:18 pmRNSTransaction in Own Shares
28th Feb 20252:40 pmRNSTotal Voting Rights
28th Feb 20251:21 pmRNSPublication of Suppl.Prospcts
28th Feb 202512:28 pmRNSPublication of Suppl.Prospcts
27th Feb 20256:16 pmRNSTransaction in Own Shares
27th Feb 20253:44 pmRNS2024 Form 20F Filed
27th Feb 20252:00 pmRNS2024 Annual Report and Accounts
27th Feb 20252:00 pmRNS2024 Annual Report and Accounts
27th Feb 20252:00 pmRNS2024 Annual Report and Accounts
27th Feb 202512:00 pmRNSDirector/PDMR Shareholding
27th Feb 20259:05 amRNS2024 Annual Report and Accounts
25th Feb 20256:22 pmRNSTransaction in Own Shares
24th Feb 20255:50 pmRNSTransaction in Own Shares
24th Feb 202512:27 pmRNSDirector/PDMR Shareholding
21st Feb 20255:56 pmRNSTransaction in Own Shares
21st Feb 202512:54 pmRNSPublication of Suppl.Prospcts
21st Feb 20257:10 amRNSCommencement of Share Buyback Programme
21st Feb 20257:00 amRNS2024 Form 20F Filed
20th Feb 20257:00 amRNS2024 Results
20th Feb 20257:00 amRNS2024 Annual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.